| Product Code: ETC6176820 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Cell and Gene Therapy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Cell and Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Cell and Gene Therapy Market - Industry Life Cycle |
3.4 Australia Cell and Gene Therapy Market - Porter's Five Forces |
3.5 Australia Cell and Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Australia Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Australia Cell and Gene Therapy Market Revenues & Volume Share, By Delivery Mode, 2021 & 2031F |
3.8 Australia Cell and Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Cell and Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Australia, driving the demand for innovative cell and gene therapies. |
4.2.2 Supportive government initiatives and policies promoting research and development in the cell and gene therapy sector. |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapies, limiting affordability and access for some patients. |
4.3.2 Regulatory challenges and uncertainties surrounding approval processes for cell and gene therapy products in Australia. |
5 Australia Cell and Gene Therapy Market Trends |
6 Australia Cell and Gene Therapy Market, By Types |
6.1 Australia Cell and Gene Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Cell and Gene Therapy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Australia Cell and Gene Therapy Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Australia Cell and Gene Therapy Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 Australia Cell and Gene Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Cell and Gene Therapy Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.3 Australia Cell and Gene Therapy Market Revenues & Volume, By Oncology Disorder, 2021- 2031F |
6.2.4 Australia Cell and Gene Therapy Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.2.5 Australia Cell and Gene Therapy Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.2.6 Australia Cell and Gene Therapy Market Revenues & Volume, By Neurological Disorder, 2021- 2031F |
6.2.7 Australia Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Cell and Gene Therapy Market, By Delivery Mode |
6.3.1 Overview and Analysis |
6.3.2 Australia Cell and Gene Therapy Market Revenues & Volume, By In-Vivo, 2021- 2031F |
6.3.3 Australia Cell and Gene Therapy Market Revenues & Volume, By Ex-Vivo, 2021- 2031F |
6.4 Australia Cell and Gene Therapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Cell and Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Cell and Gene Therapy Market Revenues & Volume, By Cancer Care Centers, 2021- 2031F |
6.4.4 Australia Cell and Gene Therapy Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.5 Australia Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Cell and Gene Therapy Market Import-Export Trade Statistics |
7.1 Australia Cell and Gene Therapy Market Export to Major Countries |
7.2 Australia Cell and Gene Therapy Market Imports from Major Countries |
8 Australia Cell and Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted in the field of cell and gene therapy in Australia. |
8.2 Investment trends in the Australian cell and gene therapy market. |
8.3 Number of partnerships and collaborations between academia, industry, and government entities in advancing cell and gene therapy research and development in Australia. |
9 Australia Cell and Gene Therapy Market - Opportunity Assessment |
9.1 Australia Cell and Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Australia Cell and Gene Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Australia Cell and Gene Therapy Market Opportunity Assessment, By Delivery Mode, 2021 & 2031F |
9.4 Australia Cell and Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Cell and Gene Therapy Market - Competitive Landscape |
10.1 Australia Cell and Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 Australia Cell and Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here